Atlas Trials

A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors

Clinical trial NCT00217152 · TERMINATED

Trial details

NCT number
NCT00217152
Sponsor
Mayo Clinic
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Kidney TransplantationDelayed Graft Function
Start date
2005-03-01
Primary completion
2007-08-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.